Natalya V. Anufrieva
Engelhardt Institute of Molecular Biology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Natalya V. Anufrieva.
Journal of Biological Chemistry | 2015
Nikita A. Kuznetsov; Nicolai G. Faleev; Alexandra A. Kuznetsova; Elena A. Morozova; Svetlana V. Revtovich; Natalya V. Anufrieva; Alexei Nikulin; Olga S. Fedorova; Tatyana V. Demidkina
Background: Speculative chemical mechanism of methionine γ-lyase is formulated, kinetic and structural data concerning elementary stages of physiological reaction are mostly lacking. Results: Pre-steady-state kinetic and structural analysis of the enzyme interaction with inhibitors was performed. Conclusion: Results elucidate the mechanism of intermediate interconversion at initial stages of enzymatic reaction. Significance: The data serve for understanding detailed mechanism of pyridoxal 5′-phosphate-dependent γ-elimination reaction. Methionine γ-lyase (MGL) catalyzes the γ-elimination of l-methionine and its derivatives as well as the β-elimination of l-cysteine and its analogs. These reactions yield α-keto acids and thiols. The mechanism of chemical conversion of amino acids includes numerous reaction intermediates. The detailed analysis of MGL interaction with glycine, l-alanine, l-norvaline, and l-cycloserine was performed by pre-steady-state stopped-flow kinetics. The structure of side chains of the amino acids is important both for their binding with enzyme and for the stability of the external aldimine and ketimine intermediates. X-ray structure of the MGL·l-cycloserine complex has been solved at 1.6 Å resolution. The structure models the ketimine intermediate of physiological reaction. The results elucidate the mechanisms of the intermediate interconversion at the stages of external aldimine and ketimine formation.
Acta Crystallographica Section D-biological Crystallography | 2014
Elena A. Morozova; Svetlana V. Revtovich; Natalya V. Anufrieva; Vitalia V. Kulikova; Alexey D. Nikulin; Tatyana V. Demidkina
The interaction of Citrobacter freundii methionine γ-lyase (MGL) and the mutant form in which Cys115 is replaced by Ala (MGL C115A) with the nonprotein amino acid (2R)-2-amino-3-[(S)-prop-2-enylsulfinyl]propanoic acid (alliin) was investigated. It was found that MGL catalyzes the β-elimination reaction of alliin to form 2-propenethiosulfinate (allicin), pyruvate and ammonia. The β-elimination reaction of alliin is followed by the inactivation and modification of SH groups of the wild-type and mutant enzymes. Three-dimensional structures of inactivated wild-type MGL (iMGL wild type) and a C115A mutant form (iMGL C115A) were determined at 1.85 and 1.45 Å resolution and allowed the identification of the SH groups that were oxidized by allicin. On this basis, the mechanism of the inactivation of MGL by alliin, a new suicide substrate of MGL, is proposed.
Iubmb Life | 2017
Vitalia V. Kulikova; Elena A. Morozova; Svetlana V. Revtovich; Mikhail I. Kotlov; Natalya V. Anufrieva; Natalya P. Bazhulina; Samanta Raboni; Serena Faggiano; Edi Gabellieri; Patrizia Cioni; Yury F. Belyi; Andrea Mozzarelli; Tatyana V. Demidkina
The exploitation of methionine‐depleting enzyme methionine γ‐lyase (MGL) is a promising strategy against specific cancer cells that are strongly dependent on methionine. To identify MGL from different sources with high catalytic activity and efficient anticancer action, we have expressed and characterized MGL from Clostridium novyi and compared its catalytic efficiency with the previously studied MGL from Citrobacter freundii. The purified recombinant MGL exhibits kcat and kcat/Km for methionine γ‐elimination reaction that are 2.4‐ and 1.36‐fold higher than C. freundii enzyme, respectively, whereas absorption, fluorescence, and circular dichroism spectra are very similar, as expected on the basis of 87% sequence identity and high conservation of active site residues. The reactivity of cysteine residues with DTNB and iodoacetamide was investigated as well as the impact of their chemical modification on catalytic activity. This information is relevant because for increasing bioavailability and reducing immunogenity, MGL should be decorated with polyethylene glycol (PEG). It was found that Cys118 is a faster reacting residue, which results in a significant decrease in the γ‐elimination activity. Thus, the protection of Cys118 before conjugation with cysteine‐reacting PEG represents a valuable strategy to preserve MGL activity. The anticancer action of C. novyi MGL, evaluated in vitro against prostate (PC‐3), chronic myelogenous leucemia (K562), and breast (MDA‐MB‐231 and MCF7) cancer cells, exhibits IC50 of 1.3 U mL−1, 4.4 U mL−1, 1.2 U mL−1, and 3.4 U mL−1, respectively. A higher cytotoxicity of C. novyi MGL was found against cancer cells with respect to C. freundii MGL, with the exception of PC‐3, where a lower cytotoxicity was observed.
Biochimica et Biophysica Acta | 2017
Svetlana V. Revtovich; Elena A. Morozova; Vitalia V. Kulikova; Natalya V. Anufrieva; T. I. Osipova; Vasiliy S. Koval; Alexey Nikulin; Tatyana V. Demidkina
The mutant form of Citrobacter freundii methionine γ-lyase with the replacement of active site Cys115 for His has been found to be inactive in the γ-elimination reaction of methionine while fully active in the γ-elimination reaction of O-acetyl-l-homoserine and in the β-elimination reaction of S-alk(en)yl-substituted cysteines. In this work, the crystal structure of the mutant enzyme complexed with competitive inhibitor, l-norleucine was determined at 1.45Å resolution. At the enzyme active site the inhibitor proved to be bound both noncovalently and covalently, which corresponds to the two intermediates of the γ- and β-elimination reactions, Michaelis complex and the external aldimine. Analysis of the structure allowed us to suggest the possible reason for the inability of the mutant enzyme to catalyze the physiological reaction.
Biochimie | 2014
Svetlana V. Revtovich; Nicolai G. Faleev; Elena A. Morozova; Natalya V. Anufrieva; Alexey D. Nikulin; Tatyana V. Demidkina
Biochimica et Biophysica Acta | 2015
Natalya V. Anufrieva; Nicolai G. Faleev; Elena A. Morozova; Natalia P. Bazhulina; Svetlana V. Revtovich; Vladimir P. Timofeev; Yaroslav V. Tkachev; Alexei Nikulin; Tatyana V. Demidkina
Biochimie | 2016
Elena A. Morozova; Vitalia V. Kulikova; Alexei Rodionov; Svetlana V. Revtovich; Natalya V. Anufrieva; Tatyana V. Demidkina
Acta Naturae | 2015
Natalya V. Anufrieva; Morozova Ea; Vitalia V. Kulikova; Bazhulina Np; Manukhov; Degtev Di; Gnuchikh Ey; Rodionov An; Zavilgelsky Gb; Tatyana V. Demidkina
Acta Naturae | 2013
Elena Morozova; Vitalia V. Kulikova; D V Yashin; Natalya V. Anufrieva; Natalia Yu Anisimova; Svetlana V. Revtovich; Mikhail I. Kotlov; Yury F. Belyi; Vadim S. Pokrovsky; Tatyana V. Demidkina
Iubmb Life | 2016
Vitalia V. Kulikova; Natalya V. Anufrieva; Svetlana V. Revtovich; Alexander S. Chernov; Georgii B. Telegin; Elena A. Morozova; Tatyana V. Demidkina